METROPOLIS2023-07-012023-09-30 METROPOLIS2023-07-012023-09-30 METROPOLIS2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member METROPOLIS2023-07-012023-09-30in-bse-fin:OneOperatingExpenses02Member METROPOLIS2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member METROPOLIS2023-07-012023-09-30in-bse-fin:FourOperatingExpenses02Member METROPOLIS2023-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 542650 METROPOLIS NOTLISTED Metropolis Healthcare Limited Equity 2023-04-01 2024-03-31 2023-11-04 2023-10-29 INR Lakhs Half yearly 14:00:00 17:55:00 2023-11-04 2023-11-04 true Cash Flow Indirect Not applicable Single segment Pathology Services 2023-07-01 2023-09-30 Unaudited Consolidated 3085006000.00 12190000.00 3097196000.00 612659000.00 0.00 0.00 697543000.00 56784000.00 222394000.00 1026696000.00 2616076000.00 481120000.00 0.00 481120000.00 143318000.00 -18798000.00 124520000.00 0.00 356600000.00 0.00 0.00 0.00 0.00 356600000.00 -40675000.00 315925000.00 354549000.00 2051000.00 313908000.00 2017000.00 102441000.00 2 6.92 6.90 0.00 0.00 6.92 6.90 1. Metropolis Healthcare Limited ( 'Company’ or ‘Parent') and its subsidiaries (referred collectively as the ‘Group’) are primarily involved in providing pathology and related healthcare services. 2. Disclosure of segment –wise information is not applicable, as pathology services is the Group’s only business segment. 3. The Board, at their meeting held on 11 February 2022, accorded in-principle approval for voluntary liquidation of Dr. Ganesan’s Hitech Diagnostic Centre Private Limited (‘Hitech’), a wholly owned subsidiary of Company, to be carried out under provisions of Insolvency and Bankruptcy Code, 2016. Board of Hitech in their meeting dated 01 April 2022 and members of Hitech in their Extra Ordinary General meeting held on 01 April 2022 have accorded their approval for consolidation of business of Hitech through voluntary liquidation process. Pursuant to ongoing liquidation process, liquidator of Hitech has transferred entire business undertaking to Company on a going concern basis on and with effect from 04 June 2022. 4.On 16 November 2022, Income Tax department conducted searches at premises of Company and some of its subsidiaries. No assets of Company or its subsidiaries were seized during this process. Company has been providing from time to time information and clarifications sought by Income Tax authorities. Subsequently, including during current quarter, Company and some of its subsidiaries have received notices under sections 142(1), 143(2), 147 and 148 of Income Tax Act,1961, that provide for reopening of past assessment proceedings. Presently, there is no demand, and accordingly, no adjustments have been made in the financial results. 5.The Board of Company have approved interim dividend of Rs. 4 per equity shares at the meeting held on 04 November 2023. 6.Other expense for the quarter and six months period ended 30 September 2023 includes Rs 334.19 lakhs on account of provision for doubtful debtors as an outcome of investigation relating to a whistle blower complaint. 7.Board of Company has accorded their approval for entering into a Settlement agreement with the equity shareholder(s) of Star Metropolis Health Services Middle East LLC – Dubai, associate of the Company (‘ the Associate’) inter-alia to enable liquidation of the Associate as per the applicable laws. 8.On review of pattern of consumption of future economic benefits embodied in the assets, it was noted that there has been change in expected pattern of consumption of these benefits. Accordingly, with effect from 01 April 2023, Group has changed its depreciation/amortization method to Straight Line method from Written down value method for various class of assets to reflect this change. Such a change has been accounted for as a change in an accounting estimate in accordance with Ind AS 8 “Accounting Policies, Change in Accounting Estimates and Errors”. Had the Group continued previous Written Down Value Method for charging depreciation on all class of assets, charge for depreciation/amortisation for the quarter and six months period ended 30 September 2023 and for future period would have been higher by Rs. 295.29 lakhs, Rs. 568.55 lakhs and Rs. 714.45 lakhs respectively and consequentially deferred tax charge on the same for the quarter and six months period ended 30 September 2023 and for future period would have been lower by Rs. 74.32 lakhs, Rs.143.10 lakhs and Rs.179.83 lakhs respectively. *Kindly take note that due to restriction of characters all the notes are not covered please refer full financials filed in pdf mode for notes on financial results Single segment 2023-04-01 2023-09-30 Unaudited Consolidated 5855917000.00 42715000.00 5898632000.00 1182253000.00 0.00 0.00 1348126000.00 116590000.00 430599000.00 1948044000.00 5025612000.00 873020000.00 0.00 873020000.00 254113000.00 -27498000.00 226615000.00 0.00 646405000.00 0.00 0.00 0.00 0.00 646405000.00 -63617000.00 582788000.00 642509000.00 3896000.00 578906000.00 3882000.00 102441000.00 2 12.55 12.50 0.00 0.00 12.55 12.50 Laboratory testing charges 28099000.00 Other expenses 998597000.00 Laboratory testing charges 52303000.00 Other expenses 1895741000.00 28668000.00 1450230000.00 0.00 0.00 4546837000.00 3514212000.00 255273000.00 0.00 0.00 17528000.00 0.00 0.00 199833000.00 217361000.00 72730000.00 2007586000.00 12064229000.00 435806000.00 361062000.00 1229019000.00 509303000.00 204206000.00 0.00 79122000.00 2382712000.00 0.00 208626000.00 3027144000.00 0.00 0.00 15091373000.00 102441000.00 10362556000.00 10464997000.00 10493665000.00 0.00 1192133000.00 1192133000.00 146621000.00 754785000.00 2093539000.00 440349000.00 811880000.00 812259000.00 2064488000.00 243048000.00 114392000.00 82241000.00 2504169000.00 4597708000.00 15091373000.00 116590000.00 10107000.00 -10226000.00 0.00 -49169000.00 0.00 49407000.00 0.00 0.00 -133810000.00 0.00 47413000.00 0.00 430599000.00 0.00 15258000.00 0.00 -36034000.00 0.00 6366000.00 0.00 11261000.00 2341000.00 -3173000.00 0.00 0.00 0.00 -4000.00 0.00 434404000.00 1307424000.00 0.00 221486000.00 0.00 0.00 0.00 1085938000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1419000.00 282127000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6474000.00 0.00 -206379000.00 0.00 -480613000.00 0.00 0.00 0.00 0.00 0.00 0.00 21000.00 0.00 0.00 350174000.00 271477000.00 0.00 0.00 113839000.00 0.00 0.00 -735469000.00 -130144000.00 -48885000.00 -179029000.00 688332000.00 509303000.00 10639000.00 14732000.00 30036000.00 48885000.00